Stock EYPT EYEPOINT PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Insiders EyePoint Pharmaceuticals, Inc.

Equities

EYPT

US30233G2093

Real-time Estimate Cboe BZX
Other stock markets
 03:20:30 2024-04-29 pm EDT 		5-day change 1st Jan Change
17.82 USD +6.39% Intraday chart for EyePoint Pharmaceuticals, Inc. +4.10% -23.65%
Apr. 02 EyePoint Pharmaceuticals, Inc. Expands Scientific Advisory Board CI
Mar. 18 EyePoint Pharmaceuticals, Inc.(NasdaqGM:EYPT) added to S&P Pharmaceuticals Select Industry Index CI

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
EyePoint Pharmaceuticals, Inc. Expands Scientific Advisory Board
CI
EyePoint Pharmaceuticals Names Ramiro Ribeiro Chief Medical Officer
MT
EyePoint Pharmaceuticals, Inc. Announces Executive Changes
CI
Eyepoint Pharmaceuticals Insider Sold Shares Worth $1,265,539, According to a Recent SEC Filing
MT
Eyepoint Pharmaceuticals Insider Sold Shares Worth $660,370, According to a Recent SEC Filing
MT
Eyepoint Pharmaceuticals Insider Sold Shares Worth $297,621, According to a Recent SEC Filing
MT
Eyepoint Pharmaceuticals Insider Sold Shares Worth $409,790, According to a Recent SEC Filing
MT
Eyepoint Pharmaceuticals Insider Sold Shares Worth $795,191, According to a Recent SEC Filing
MT
Eyepoint Pharmaceuticals Insider Sold Shares Worth $484,124, According to a Recent SEC Filing
MT
Eyepoint Pharmaceuticals Insider Sold Shares Worth $19,510,637, According to a Recent SEC Filing
MT
EyePoint Pharmaceuticals Insider Sold Shares Worth $19,510,637, According to a Recent SEC Filing
MT
Eyepoint Pharmaceuticals Insider Sold Shares Worth $990,000, According to a Recent SEC Filing
MT
Eyepoint Pharmaceuticals Insider Sold Shares Worth $415,200, According to a Recent SEC Filing
MT
EyePoint Pharmaceuticals, Inc. Announces Executive Changes
CI
Akari Therapeutics Names Wendy DiCicco Interim Finance Chief
MT
EyePoint Pharmaceuticals Names Jay Duker CEO; Shares Climb
MT
EyePoint Pharmaceuticals Names Jay Duker CEO
MT
Eyepoint Pharmaceuticals, Inc. Announces Chief Executive Officer Changes
CI
Eyepoint Pharmaceuticals, Inc. Announces Executive Changes
CI
Eyepoint Pharmaceuticals Promotes Jay S. Duker, M.D. to President and Chief Operating Officer
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. EYPT Stock
  4. News EyePoint Pharmaceuticals, Inc.
  5. Insiders